Data released from a successful phase 3 trial validate an approach that Rockefeller’s Nathaniel Heintz has pioneered for decades—and could pave the way for a new generation of neurological drugs.

Nathaniel Heintz has spent decades building tools to peer inside individual brain cell types—now he's using those tools to spot some of the earliest changes that occur in neurodegenerative diseases.

Thirty years ago, an insight from a rare brain disease took Robert Darnell's career in an unexpected direction. He’s still surprised by what he’s learning.

In a new study, scientists uncover thousands of previously hidden genes and reveal ancient chromosome structures, with sweeping implications for the study of neuroscience and evolution.

FlatMux captures electrical activity optically from nearly 200 genetically defined neurons across brain circuits, revealing how signals flow, cells connect, and computations emerge in a living mouse brain.

The brain activity that occurs during the act of drawing reveals fundamental neural properties and has implications for the improvement of brain-computer interfaces and the study of brain disorders.

The two scientists are the 35th and 36th members of Rockefeller's current faculty to be honored with membership in the prestigious academy founded by Abraham Lincoln.

New work in fruit flies uncovers an electrical trick that allows neurons to compute direction efficiently by juggling multiple signaling mechanisms. These findings could reframe our understanding of how some neurons operate.

New work demonstrates how neural circuits in the brain and muscles of the face work together to respond physically to social cues.

Boosting PI31 has been shown to head off Parkinson’s-like disorders and extend lifespan in fruit flies and mice, pointing to a possible new therapeutic target for treating rare neurodegenerative diseases, as well as more common disorders, such as Alzheimer's.
View
View